logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5127.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5127.produseast1
Clinical utility of target-based next-generation sequencing for drug-resistant tuberculosis: a pilot from Mumbai, India | Conference Material / Video | MSF Science Portal
Conference Material
|Video

Clinical utility of target-based next-generation sequencing for drug-resistant tuberculosis: a pilot from Mumbai, India

Mansoor H, Hirani N, Chavan VV, Joshi A, Oswal V, Sharma J, Iyer AS, England K, Ndlovu Z, Silsarma A, Isaakidis P, Morales M
Similar Content
Slide Presentation
|Slide Presentation
Clinical utility of target-based next-generation sequencing for drug-resistant tuberculosis: a pilot from Mumbai, India
2022 May 11 • MSF Scientific Days International 2022
Abstract
|Abstract
Clinical utility of target-based next-generation sequencing for drug-resistant tuberculosis: a pilot from Mumbai, India
2022 May 11 • MSF Scientific Days International 2022
Loading...

Countries

India

Subject Area

antibiotic resistancetuberculosisdiagnosticsgenetics & genomicsantimicrobial resistance

Languages

English
DOI
10.57740/3gdn-kn91
Published Date
07 Jun 2022
Conference
MSF Scientific Days International 2022
Linked Content
Conference Material
|Slide Presentation
Clinical utility of target-based next-generation sequencing for drug-resistant tuberculosis: a pilot from Mumbai, India
2022 May 11 • MSF Scientific Days International 2022
Conference Material
|Abstract
Clinical utility of target-based next-generation sequencing for drug-resistant tuberculosis: a pilot from Mumbai, India
2022 May 11 • MSF Scientific Days International 2022